Medication reference
Idarucizumab
Monograph awaiting updateThis monograph will be updated in the future.
No original site article was mapped to this record. The available historical structured fields and official-source links are retained.
Historical first look: uses, mechanism, dosing context, and administration
Recovered v5.1 source content; historical, awaiting current review.
- Id
- idarucizumab
Source ID
H51-D425D3C5C1D93A87BEB6589F - Generic name
- Idarucizumab
Source ID
H51-13B65B862AAD2A77FDF1A809 - Class
- Anticoagulation and hemostasis
Source ID
H51-B691EB5E7652A59250A19658 - Subclass
- Dabigatran reversal antibody fragment
Source ID
H51-2297D326132C2D9B96987322 - Primary uses
- Urgent reversal of dabigatran for life-threatening bleeding or emergency surgery
Source ID
H51-72C07DAD363E0C354E92DE2D
- Urgent reversal of dabigatran for life-threatening bleeding or emergency surgery
- Mechanism
- A high-affinity antibody fragment that binds dabigatran and neutralizes its anticoagulant activity.
Source ID
H51-E33D492F0E9C33600B6F8958 - Mechanism level
- drug_specific
Source ID
H51-38995DC515320B76BEAFD262 - Basic dosing orientation
- Adult | Existing preparation record; use current package insert for indication-specific selection | 5 g total as two consecutive 2.5 g/50 mL vials | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Adult | 2.5 g vial x 2 | 2.5 g vial x 2 | Patient- and indication-specific | See current package insert | IV push
Source ID
H51-E59DAD5CA1E2ACC26C125F46 - Administration orientation
- Administer as two consecutive infusions or syringe injections according to label; Each vial may be administered by syringe injection per current label; 50 mg/mL; Each vial may be administered by syringe injection per current label
Source ID
H51-FBB8C9B5844EFB523616D982 - Renal and population orientation
- Separate renal reference: Open Renal Dosing Master (opens in a new tab)The existing monograph contains a renal or nephrotoxicity signal; verify exact adjustment and monitoring in the current label.
Source ID
H51-B361FDE6863C4BD1CBF069C1 - Key safety orientation
- Thromboembolic risk from reversal and underlying disease.
Source ID
H51-42CFBA0D49E49B5A34D686F9 - Dabigatran concentrations can rebound in selected patients.
Source ID
H51-05C76B362C48ECA8A3D1FCED
- Thromboembolic risk from reversal and underlying disease.
- Coverage path
- structured_local_snapshot
Source ID
H51-FA4E0E7130FC0382E756184E - Coverage path label
- Structured GlobalRPh route snapshot
Source ID
H51-CA049176351522CB42DFB9D9 - Official label url
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c7400f8a-dcf4-a6df-6d07-983081b1bf34 (opens in a new tab)
Source ID
H51-6F3EC70A40011E5B57BD46FD - Review note
- First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
Source ID
H51-63411640276E16771108B302 - Search text
- Idarucizumab Anticoagulation and hemostasis Dabigatran reversal antibody fragment Urgent reversal of dabigatran for life-threatening bleeding or emergency surgery A high-affinity antibody fragment that binds dabigatran and neutralizes its anticoagulant activity. Adult | Existing preparation record; use current package insert for indication-specific selection | 5 g total as two consecutive 2.5 g/50 mL vials | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Adult | 2.5 g vial x 2 | 2.5 g vial x 2 | Patient- and indication-specific | See current package insert | IV push Administer as two consecutive infusions or syringe injections according to label; Each vial may be administered by syringe injection per current label; 50 mg/mL; Each vial may be administered by syringe injection per current label The existing monograph contains a renal or nephrotoxicity signal; verify exact adjustment and monitoring in the current label. Thromboembolic risk from reversal and underlying disease. Dabigatran concentrations can rebound in selected patients. Structured GlobalRPh route snapshot PRAXBIND PRAXBIND (idarucizumab) injection, solution DailyMed label snapshot dosage administration dosage forms strengths mechanism
Source ID
H51-2EE4B1F98535ED837F0743C5 - Official search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Idarucizumab (opens in a new tab)
Source ID
H51-2E171AB02C817B9CB776E72F - Official access mode
- direct_label
Source ID
H51-A32838FE1D5C9B21A487763B - Official access url
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c7400f8a-dcf4-a6df-6d07-983081b1bf34 (opens in a new tab)
Source ID
H51-D251AED467AF911FCBD41695 - Official search query
- Idarucizumab
Source ID
H51-93F59502D4BC6B167D77C358 - Official access reason
- Very-high-confidence exact IV product label selected during the v5.1 build-time review. Open the current full DailyMed monograph and verify the stocked product before use.
Source ID
H51-E570F75735AE2027BED6F35E - Label snapshot available
- true
Source ID
H51-89C5DFCADA3FD061B32C543B - Label snapshot setid
- c7400f8a-dcf4-a6df-6d07-983081b1bf34
Source ID
H51-6E7D9C2E47C17242DBFEEC1C
Product identifiers and clinical review status
This monograph will be updated in the future. Historical material is available where present in the original sources; full current exact-product and claim-level review remains pending.
Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.
What remains to be completed
- A retrieved source document is available; clinical reconciliation and a second-source claim map remain incomplete
- Clinically reviewed, individually identified statements with two exact source mappings
- Exact formulation, strength, container, manufacturer/labeler, application and NDC reconciliation
- Renal-function methods and dialysis/CRRT modality review where applicable
- Mechanism provenance, clinical source disagreements and full medication-specific safety reconciliation
Supplemental historical fields
Restored-data provenance and review notes
Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.
Current review annotations for historical renal, dialysis, mechanism, and product fields
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Renal
- Status
- not_locally_normalized
- Original classification
- renal_review_flagged
- Entries
- General note
- Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
- Dialysis
- Status
- no_local_structured_regimen
- Entries
- General note
- Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
- Mechanisms
- Source kind
- first_look
- Local pointer
- /mechanism
- Original level
- drug_specific
- Provenance classification
- historical_drug_specific_uncorroborated
- Label derived verified
- false
- Independently corroborated
- false
- Exact label section
- Not recorded
- Original source note
- Not recorded
- Review status
- historical_unverified
- Note
- Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
- Source kind
- label_snapshot
- Local pointer
- /mechanism_summary
- Original level
- drug_specific
- Provenance classification
- historical_drug_specific_uncorroborated
- Label derived verified
- false
- Independently corroborated
- false
- Exact label section
- Not recorded
- Original source note
- Concise GlobalRPh summary reviewed against the selected DailyMed label clinical-pharmacology or microbiology content.
- Review status
- historical_unverified
- Note
- Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
- Future update
- Status
- pending_review
- Message
- This monograph will be updated in the future as current exact-product and claim-level review is completed.
- Source unavailable
- false
- Reason
- The historical content is restored; comprehensive contemporary verification remains incomplete.
No separate structured rows were bundled for continuous infusion, dialysis, CRRT. Historical article content and source links may cover these topics.
Historical dilution and intermittent infusion preparation
Recovered v5.1 source content; historical, awaiting current review.
| Population | Amount | Reconstitution | Diluent | Final volume | Concentration | Rate | Stability | Notes |
|---|---|---|---|---|---|---|---|---|
Source IDH51-F0D0627F6FD1D5FEF7079EA7Source IDH51-6A823559116750EA179D325D | 5 g total as two consecutive 2.5 g/50 mL vialsSource IDH51-CB3CFA1793E8433D1AA4171F | No dilution required.Source IDH51-5E51BA71F20FFA2596616204 | Ready-to-useSource IDH51-F29F8805C14FF601888C5F74 | 100 mL totalSource IDH51-8021CAF9772DCC5047EC4A8B | 50 mg/mLSource IDH51-644B7995A51EAEE0F0459BFE | Administer as two consecutive infusions or syringe injections according to labelSource IDH51-FF16C83A1811657DDB9E1DB8 | Use promptly after vial opening and follow current label for allowable room-temperature exposure.Source IDH51-CC084BB18AFB064C69159A7C | Use a separate IV line or flush with NS before and after.Source IDH51-A703814F56599866580A0E84 |
Historical DailyMed label snapshot
Recovered v5.1 source content; historical, awaiting current review.
- Id
- idarucizumab
Source ID
H51-F973D028871BF35D8F68C0CC - Catalog name
- Idarucizumab
Source ID
H51-8FDB0C4CF9806608243DF9F2 - Selection status
- accepted_high_confidence
Source ID
H51-17B8250B15AD185B5E61F776 - Confidence
- very_high
Source ID
H51-138150F57170EF915D8A59B7 - Match path
- search_to_exact_label
Source ID
H51-0E760427BE5A5166462C050F - Brand name
- PRAXBIND
Source ID
H51-CA7885C3B3BC150754F8B4FA - Label title
- PRAXBIND (idarucizumab) injection, solution
Source ID
H51-0AC06EC6CB52C714DFE0A273 - Setid
- c7400f8a-dcf4-a6df-6d07-983081b1bf34
Source ID
H51-4EAFCFE617D6084950BAB09D - Route
- Intravenous infusion or bolus injection
Source ID
H51-3D29FBE53570FD2D11F52673 - Dosage form
- Ready-to-use antibody-fragment solution
Source ID
H51-D2544D5E6E64C8E610DB7A98 - Dosage administration summary
- Administer a total dose of 5 g as two consecutive 2.5 g/50 mL vials.
Source ID
H51-7076B5E10128C27967C8FA0A - Each vial may be administered by intravenous infusion or bolus injection; do not mix with other medicinal products and flush the line as directed by the label.
Source ID
H51-D1D880E3DF4042A3AEC63895 - Restart anticoagulation when medically appropriate because reversal of dabigatran exposes the patient to the underlying thrombotic risk.
Source ID
H51-7CDA2FB6EE52ED1A55638965
- Administer a total dose of 5 g as two consecutive 2.5 g/50 mL vials.
- Dosage forms strengths
- 2.5 g idarucizumab in 50 mL per single-dose vial; two vials provide the 5 g dose
Source ID
H51-646E7788CE07A22131B85509
- 2.5 g idarucizumab in 50 mL per single-dose vial; two vials provide the 5 g dose
- Mechanism summary
- Idarucizumab is a humanized monoclonal-antibody fragment that binds dabigatran and its metabolites with high affinity, neutralizing their anticoagulant effect.
Source ID
H51-B51AAE41E4060D053EBEA5A8 - Scope note
- Selected PRAXBIND label. This product reverses dabigatran and is not a general reversal agent for other anticoagulants.
Source ID
H51-12497F4ACCB27F4307DD02B0 - Official label url
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c7400f8a-dcf4-a6df-6d07-983081b1bf34 (opens in a new tab)
Source ID
H51-187B35DAEEE0FE267AC5C2E4 - Reviewed on
- 2026-08-31
Source ID
H51-5D15113877AC41937F990CA9 - Mechanism source
- Concise GlobalRPh summary reviewed against the selected DailyMed label clinical-pharmacology or microbiology content.
Source ID
H51-01A45FA2B5879F2E4970841B - Source sections
- Dosage and Administration
Source ID
H51-231516268E239129456D482E - Dosage Forms and Strengths
Source ID
H51-8053F1723EBC73E8C848F80D - Clinical Pharmacology or Microbiology as applicable
Source ID
H51-BC08ACF7335468C2E313DDB5
- Dosage and Administration
- Retrieval method
- Manual build-time review of the current DailyMed full prescribing information for the selected Set ID; no live server retrieval is required during page use.
Source ID
H51-925FD0AF51F935F0D4CDB469 - Label status
- current
Source ID
H51-211AEA885BA35A30C8428643 - Disclaimer
- Verify the exact formulation, strength, manufacturer, NDC, route, current label revision, patient-specific order, institutional policy, and monitoring before use.
Source ID
H51-448BD7C133CD2CB050445D09
Historical IV-push guidance
Recovered v5.1 source content; historical, awaiting current review.
| Population | Dose scope | Concentration | Rate | Status | Notes |
|---|---|---|---|---|---|
Source IDH51-992350FD182818BAD223145ESource IDH51-A307FB39C96D44531D575005 | 2.5 g vial x 2Source IDH51-714F0519FD9606D2B2A0E0CE | 50 mg/mLSource IDH51-43C6358A9E1C45857D59B1D8 | Each vial may be administered by syringe injection per current labelSource IDH51-29B2C468D040C31F70FB58BB | Label-standard reversal useSource IDH51-766511B46E5B650A2C5FF3A9 | Confirm exact label method and local emergency protocol.Source IDH51-BDA569FFB7080C949636C055 |
Historical indication and population dosing
Recovered tables and source-separated snapshots; full clinical revalidation remains pending.
Existing dose and route snapshots
| Route | Population | Indication | Dose | Interval | Duration | Administration | Source level | Notes |
|---|---|---|---|---|---|---|---|---|
Source IDH51-842F7E111DD4A5759412BAB7Source IDH51-525AAB716F36C184C04D1B98 | AdultSource IDH51-448767A1266E0F1E16C94FDE | Existing preparation record; use current package insert for indication-specific selectionSource IDH51-7D1275A01FF9C110A25325BE | 5 g total as two consecutive 2.5 g/50 mL vialsSource IDH51-D8081A985FB9F0D336DC107A | Not normalized in the preparation recordSource IDH51-81081F7F9C838E094541413C | See current package insert and professional guidanceSource IDH51-18225BDC3E0649ECA8D392B2 | Administer as two consecutive infusions or syringe injections according to labelSource IDH51-1ABC4A4DD96982FDDC61955F | Existing GlobalRPh structured preparation snapshotSource IDH51-BC801E317DA0CA5C7AA94317 | Use a separate IV line or flush with NS before and after.Source IDH51-8859EC958419D3092E0F76E6 |
Source IDH51-3FB9CB59460B7C159044362CSource IDH51-883E3EDA822D310834E04A63 | AdultSource IDH51-DFD39E9CF5D6AE63461272D0 | 2.5 g vial x 2Source IDH51-03F659456B4EE72B718CDCEB | 2.5 g vial x 2Source IDH51-07D74C4C4F3DA5B06CC8EA2E | Patient- and indication-specificSource IDH51-382F542F29FCB4F50699E4E4 | See current package insertSource IDH51-A6B813666A0CFFF1ADC87E83 | Each vial may be administered by syringe injection per current labelSource IDH51-3F4099A4B364BC163712011D | Existing GlobalRPh IV push snapshotSource IDH51-C38EAF957107983D4D8052D0 | Label-standard reversal use Confirm exact label method and local emergency protocol.Source IDH51-E602BC10F95F428B19BE3338 |
Historical renal-function guidance
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Classification
- renal_review_flagged
Source ID
H51-B710C79FEF398C3CC49FC8B9 - Summary
- The existing monograph contains a renal or nephrotoxicity signal; verify exact adjustment and monitoring in the current label.
Source ID
H51-C45451674211177D9035D2D4 - Method note
- Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
Source ID
H51-FF6515CA37F0BCE43D7C0119
Historical Common IV uses
Recovered v5.1 source content; historical, awaiting current review.
- Urgent reversal of dabigatran for life-threatening bleeding or emergency surgery
Source ID
H51-20C6F6166C532A156C79F43A
Historical Warnings and safeguards
Recovered v5.1 source content; historical, awaiting current review.
- Thromboembolic risk from reversal and underlying disease.
Source ID
H51-013492D85F6A2C410BB220AC - Dabigatran concentrations can rebound in selected patients.
Source ID
H51-8263EC42DC2D41C964208986
Historical Monitoring
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Hemostasis and coagulation tests when informative
Source ID
H51-43EEEC75E26CA62A77D69536 - Renal function
Source ID
H51-24FDDF0FAF7A3EECA801E4A6 - Thrombotic events and anticoagulation restart
Source ID
H51-DD3CEE06934EA3AC207E10F1
Other recovered source fields and original editorial metadata
Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.
Catalog source fields
Id
idarucizumabSource ID
H51-0591340D628A10A3B3440114Generic name
IdarucizumabSource ID
H51-5962B280182ED8124608C46BBrand names
- Praxbind
Source ID
H51-DF2086356B17D95D9DC3DC0E
Class
Anticoagulation and hemostasisSource ID
H51-EB75B3273565868D54CAFB7ASubclass
Dabigatran reversal antibody fragmentSource ID
H51-44A1E37DFA31F6E56DB82509Summary
Ready-to-use specific reversal agent supplied as two 2.5 g/50 mL vials for a total 5 g dose.Source ID
H51-BC8F3A13AEB9A91A58E82E8CPopulations
- Adult
Source ID
H51-8754E5921AB2BDC24B7943A9
Evidence tier
Core reference - verify current labelSource ID
H51-BBC96C6EA5E601BB8B74C950High alert
trueSource ID
H51-C62D3560EAF90EC060B33DC2Hazardous
falseSource ID
H51-14753AEF69296306C99B5B0CStatus
ActiveSource ID
H51-7D7E4744FF1D332100D38EDAReviewed
2026-08-29Source ID
H51-DB64CBA222A0D6C13970AA4FVersion added
1.2Source ID
H51-2EAF281F7CDFA3AEC8E21A50Sources
| Label | Url | Kind |
|---|---|---|
Source IDH51-B889E08D13DEA0A1368B8CF3Source IDH51-224AB3D4CCEF6440F8A5B65F | https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Idarucizumab (opens in a new tab)Source IDH51-276DE2B2EB02E239846F72F6 | PrimarySource IDH51-B2F59CA8F9592E9DA5C2A5FB |
Source IDH51-7BC6FFA3AEFDA9CD27AC9C61Source IDH51-291D30FB129709EDDE3B0930 | legacy:autoSource IDH51-C7C6086EB58BF8093B52E118 | LegacySource IDH51-B3BEA3F1904D9F5AD847C244 |
Clinical release verification
- Audit version
- 3.4
Source ID
H51-2F629B1FCF5BF1D917F0D0C4 - Audited on
- 2026-08-30
Source ID
H51-37A8CCF3902C1132BC0ECDD7 - Level
- amber
Source ID
H51-85E6DEBA02235F74949CA179 - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-4F4CEB19290DB59739F6EA3A - Exact current label candidate
- false
Source ID
H51-C3A948B7409AD9C900C68BC9 - Numeric support ratio
- 0
Source ID
H51-F71FA45AD5455B5356508C9D - Reference url count
- 1
Source ID
H51-0FC657932630A93B85EB415A - Broken reference count
- 0
Source ID
H51-96F422379A547C5EB793DEAD - Point of use confirmation required
- true
Source ID
H51-9F98F5C7CE18B02B4C53A5FF - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-601808A02384FECDD956F612 - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Idarucizumab (opens in a new tab)
Source ID
H51-1E4496436B286B9720D939D5
Version updated
5.1Source ID
H51-67BC7D8FA10DEF636DB64978Dosing source fields
Id
idarucizumabSource ID
H51-193BDC23BF4ACE663F597E8CGeneric name
IdarucizumabSource ID
H51-554FCFE0C6853E4FD7477F81Coverage status
direct_official_label_access_plus_local_snapshotSource ID
H51-997AAFA4D7078E388DE64DFFPackage insert
- Query name
- Idarucizumab
Source ID
H51-28619DD1D3C04E3864F6AD4D - Product and route must match
- true
Source ID
H51-4AB3D4BE5A126D782558C02C - Live current label enabled
- false
Source ID
H51-6D12CFD848ABA5AA323E4D9C - Source priority
- Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
Source ID
H51-F641B02449CFEC22D54F034F - Direct official label access enabled
- true
Source ID
H51-834E7E6E9304379A6B0B6702 - Outbound server request required
- false
Source ID
H51-D5ADAA0F84ECB7150BC10DEE - Local summary status
- not_bundled
Source ID
H51-05EFC59544D0690908B5C799
Clinical review
- Locally normalized
- false
Source ID
H51-8C20C0CFDDF694416DA0953D - Reviewed
- 2026-08-29
Source ID
H51-FD74E839CFF62652A506A1B1 - Status
- Direct official package-insert access enabled; indication-specific local normalization pending.
Source ID
H51-AFADD37DD574DFD8C9B76727
Clinical release verification
- Audit version
- 3.4
Source ID
H51-27DF97C4C04325FBCEF149D7 - Audited on
- 2026-08-30
Source ID
H51-17A9178607E66636729D6BD5 - Level
- amber
Source ID
H51-265EFA157CD77E3D5589A0DE - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-9A424B3E5711BC7961DCE30F - Exact current label candidate
- false
Source ID
H51-C9772B460FCC84F7103CB10A - Numeric support ratio
- 0
Source ID
H51-2C860C70D93B76FD227F323F - Reference url count
- 1
Source ID
H51-F0C98988EF97064BE09CDEF6 - Broken reference count
- 0
Source ID
H51-6933720BAD9BC04F117D926C - Point of use confirmation required
- true
Source ID
H51-DE110D4A4980EAF4BBDA0BCE - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-9A4EEB30DE3A902126980569 - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Idarucizumab (opens in a new tab)
Source ID
H51-318C2FC9E2807ECF9D72E254
Historical preparation assessment
Recovered v5.1 source content; historical, awaiting current review.
- Id
- idarucizumab
Source ID
H51-969D994CD233FA475C6F41C6 - Name
- Idarucizumab
Source ID
H51-A6F593EAACA74C002EA65D71 - Brands
- Praxbind
Source ID
H51-ADB11FA580DEBD2F900C9DE6 - Therapeutic class
- Anticoagulation and hemostasis
Source ID
H51-3FEC019B9213A06AB03479F3 - Review version
- 3.1
Source ID
H51-06B5D780BAF41AD98EFA918D - Review date
- 2026-08-30
Source ID
H51-B77A9D9C481333EAC6D9E51F - Release status
- structured_record_current_label_not_confirmed
Source ID
H51-E5E834CD3BB12AF7B41FF7E9 - Market status
- Status
- no_current_us_iv_spl_confirmed
Source ID
H51-6886354A7424D580A2A76EA7 - Basis
- No high-confidence current IV SPL was automatically selected; legacy information is segregated
Source ID
H51-E5E57CE1DC5E227E458F1D69
- Ten point assessment
- Exact formulation
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-5C3F03959F27D49C39FF769F - Reconstitution concentration
- No dilution required.
Source ID
H51-7FA43A82321ACC02A0C8DADE - Maximum or recommended final concentration
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-63255401EAEB350271695E21 - Appropriate standardized containers
- 100 mL total
Source ID
H51-C4D6E45E19C6C1BFD831DD86 - Adult dosing range
- 5 g total as two consecutive 2.5 g/50 mL vials 2.5 g vial x 2 2.5 g vial x 2
Source ID
H51-52D8383631E04584E45F5A8F - Pediatric dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-34FE23093F74BE63D92732CE - Neonatal dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-78C75C98D369F66A94068244 - Infusion time
- Administer as two consecutive infusions or syringe injections according to label Each vial may be administered by syringe injection per current label
Source ID
H51-C2CD417F336254695D9C6869 - Fluid restriction alternatives
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-9169A4B5B767D7F2933BE5E0 - Current manufacturer labeling
- Match confidence
- unresolved
Source ID
H51-3172F777C16A3387C3188E3F - Url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Idarucizumab (opens in a new tab)
Source ID
H51-F582DD939ADE9686D98EB631
- Field provenance
- Exact formulation
- Primary
- not_found
Source ID
H51-1761C6E852151C6D9EF949E6
- Reconstitution concentration
- Primary
- existing_structured_record
Source ID
H51-35039B70F884519E01154615
- Maximum or recommended final concentration
- Primary
- not_found
Source ID
H51-FB9C0190F6548E04BC51241C
- Appropriate standardized containers
- Primary
- existing_structured_record
Source ID
H51-78F22C7DFF9C6E57FE76C76E
- Adult dosing range
- Primary
- existing_structured_record
Source ID
H51-C8CE013F55EFC8A4A7154CC2
- Pediatric dosing range
- Primary
- not_found
Source ID
H51-B020B4A4C4A7C329E5E71A2F
- Neonatal dosing range
- Primary
- not_found
Source ID
H51-2DE0FC1EE1FCB543BFAF065A
- Infusion time
- Primary
- existing_structured_record
Source ID
H51-2B8CC2BAEEF84BF0E2534FA2
- Fluid restriction alternatives
- Primary
- not_found
Source ID
H51-24231D9DD865B437089E8028
- Current manufacturer labeling
- Primary
- DailyMed search gateway
Source ID
H51-31BF1A82566EA794B8FFBD21
- Population applicability
- Adult
- Applicability
- supported_or_source_present
Source ID
H51-99B73EB39DBE80BF2D794024 - Guide generation allowed
- true
Source ID
H51-D00DF60D6F7448B528B63579
- Pediatric
- Applicability
- not_established
Source ID
H51-1246B35092D9EC45D3F56F93 - Guide generation allowed
- false
Source ID
H51-19DA0488129D1241E4C81204
- Neonatal
- Applicability
- not_established
Source ID
H51-A1BCBB598FDB2FCFE4D1B0B5 - Guide generation allowed
- false
Source ID
H51-9C17AF0A2A2ADD03014B50A4
- Route presence
- Structured dilution
- true
Source ID
H51-8CDB06D0F114C10D388A8E0A - Iv push
- true
Source ID
H51-FDAD7539776AE1CC1EF99EED - Continuous infusion
- false
Source ID
H51-29051919617A43CBC4D4D64D - Pediatric source
- false
Source ID
H51-A5ABF1E41C38472B2F461670 - Neonatal source
- false
Source ID
H51-42E098ECD5E3DE2936E04B41
- Legacy reference
- Status
- not_available
Source ID
H51-F9FE69A92F5779B604B06F0F
- Label resolution
- Status
- build_environment_network_unavailable
Source ID
H51-009719E5ED069627D6B96DD0
- Source files
- catalog.json
Source ID
H51-E62740C39C45595C431ADF56 - dosing.json
Source ID
H51-B00743281AD1905E034CA195 - new-in-v1.2.json
Source ID
H51-06B26B15ADDFC93DDEC75921
- catalog.json
- Clinical release note
- Preparation instructions are released only at the evidence level shown. Legacy content remains visibly separate. Exact product, NDC, route, current labeling, and institutional policy must be confirmed.
Source ID
H51-0628910E5DE890F166C90C81
Historical statement IDs and source locations
These IDs identify recovered source units. They are not evidence-qualified clinical claims.
| Historical ID | Original source location | Status |
|---|---|---|
H51-0591340D628A10A3B3440114 | catalog.json/records/129/id | Historical; current review incomplete |
H51-5962B280182ED8124608C46B | catalog.json/records/129/generic_name | Historical; current review incomplete |
H51-DF2086356B17D95D9DC3DC0E | catalog.json/records/129/brand_names/0 | Historical; current review incomplete |
H51-EB75B3273565868D54CAFB7A | catalog.json/records/129/class | Historical; current review incomplete |
H51-44A1E37DFA31F6E56DB82509 | catalog.json/records/129/subclass | Historical; current review incomplete |
H51-BC8F3A13AEB9A91A58E82E8C | catalog.json/records/129/summary | Historical; current review incomplete |
H51-20C6F6166C532A156C79F43A | catalog.json/records/129/common_uses/0 | Historical; current review incomplete |
H51-F0D0627F6FD1D5FEF7079EA7 | catalog.json/records/129/preparations/0 | Historical; current review incomplete |
H51-6A823559116750EA179D325D | catalog.json/records/129/preparations/0/population | Historical; current review incomplete |
H51-CB3CFA1793E8433D1AA4171F | catalog.json/records/129/preparations/0/amount | Historical; current review incomplete |
H51-5E51BA71F20FFA2596616204 | catalog.json/records/129/preparations/0/reconstitution | Historical; current review incomplete |
H51-F29F8805C14FF601888C5F74 | catalog.json/records/129/preparations/0/diluent | Historical; current review incomplete |
H51-8021CAF9772DCC5047EC4A8B | catalog.json/records/129/preparations/0/final_volume | Historical; current review incomplete |
H51-644B7995A51EAEE0F0459BFE | catalog.json/records/129/preparations/0/concentration | Historical; current review incomplete |
H51-FF16C83A1811657DDB9E1DB8 | catalog.json/records/129/preparations/0/rate | Historical; current review incomplete |
H51-CC084BB18AFB064C69159A7C | catalog.json/records/129/preparations/0/stability | Historical; current review incomplete |
H51-A703814F56599866580A0E84 | catalog.json/records/129/preparations/0/notes | Historical; current review incomplete |
H51-992350FD182818BAD223145E | catalog.json/records/129/iv_push/0 | Historical; current review incomplete |
H51-A307FB39C96D44531D575005 | catalog.json/records/129/iv_push/0/population | Historical; current review incomplete |
H51-714F0519FD9606D2B2A0E0CE | catalog.json/records/129/iv_push/0/dose_scope | Historical; current review incomplete |
H51-43C6358A9E1C45857D59B1D8 | catalog.json/records/129/iv_push/0/concentration | Historical; current review incomplete |
H51-29B2C468D040C31F70FB58BB | catalog.json/records/129/iv_push/0/rate | Historical; current review incomplete |
H51-766511B46E5B650A2C5FF3A9 | catalog.json/records/129/iv_push/0/status | Historical; current review incomplete |
H51-BDA569FFB7080C949636C055 | catalog.json/records/129/iv_push/0/notes | Historical; current review incomplete |
H51-013492D85F6A2C410BB220AC | catalog.json/records/129/warnings/0 | Historical; current review incomplete |
H51-8263EC42DC2D41C964208986 | catalog.json/records/129/warnings/1 | Historical; current review incomplete |
H51-43EEEC75E26CA62A77D69536 | catalog.json/records/129/monitoring/0 | Historical; current review incomplete |
H51-24FDDF0FAF7A3EECA801E4A6 | catalog.json/records/129/monitoring/1 | Historical; current review incomplete |
H51-DD3CEE06934EA3AC207E10F1 | catalog.json/records/129/monitoring/2 | Historical; current review incomplete |
H51-8754E5921AB2BDC24B7943A9 | catalog.json/records/129/populations/0 | Historical; current review incomplete |
H51-BBC96C6EA5E601BB8B74C950 | catalog.json/records/129/evidence_tier | Historical; current review incomplete |
H51-C62D3560EAF90EC060B33DC2 | catalog.json/records/129/high_alert | Historical; current review incomplete |
H51-14753AEF69296306C99B5B0C | catalog.json/records/129/hazardous | Historical; current review incomplete |
H51-7D7E4744FF1D332100D38EDA | catalog.json/records/129/status | Historical; current review incomplete |
H51-DB64CBA222A0D6C13970AA4F | catalog.json/records/129/reviewed | Historical; current review incomplete |
H51-2EAF281F7CDFA3AEC8E21A50 | catalog.json/records/129/version_added | Historical; current review incomplete |
H51-B889E08D13DEA0A1368B8CF3 | catalog.json/records/129/sources/0 | Historical; current review incomplete |
H51-224AB3D4CCEF6440F8A5B65F | catalog.json/records/129/sources/0/label | Historical; current review incomplete |
H51-276DE2B2EB02E239846F72F6 | catalog.json/records/129/sources/0/url | Historical; current review incomplete |
H51-B2F59CA8F9592E9DA5C2A5FB | catalog.json/records/129/sources/0/kind | Historical; current review incomplete |
H51-7BC6FFA3AEFDA9CD27AC9C61 | catalog.json/records/129/sources/1 | Historical; current review incomplete |
H51-291D30FB129709EDDE3B0930 | catalog.json/records/129/sources/1/label | Historical; current review incomplete |
H51-C7C6086EB58BF8093B52E118 | catalog.json/records/129/sources/1/url | Historical; current review incomplete |
H51-B3BEA3F1904D9F5AD847C244 | catalog.json/records/129/sources/1/kind | Historical; current review incomplete |
H51-1EAD4DE77FB68333FDDEB6F4 | catalog.json/records/129/legacy_title | Historical; current review incomplete |
H51-2F629B1FCF5BF1D917F0D0C4 | catalog.json/records/129/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-37A8CCF3902C1132BC0ECDD7 | catalog.json/records/129/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-85E6DEBA02235F74949CA179 | catalog.json/records/129/clinical_release_verification/level | Historical; current review incomplete |
H51-4F4CEB19290DB59739F6EA3A | catalog.json/records/129/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-C3A948B7409AD9C900C68BC9 | catalog.json/records/129/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-099829DE7326419E475E6FB7 | catalog.json/records/129/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-F2A7F67C7C64682CC265E6B1 | catalog.json/records/129/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-F71FA45AD5455B5356508C9D | catalog.json/records/129/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-0FC657932630A93B85EB415A | catalog.json/records/129/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-96F422379A547C5EB793DEAD | catalog.json/records/129/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-9F98F5C7CE18B02B4C53A5FF | catalog.json/records/129/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-601808A02384FECDD956F612 | catalog.json/records/129/clinical_release_verification/note | Historical; current review incomplete |
H51-1E4496436B286B9720D939D5 | catalog.json/records/129/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-67BC7D8FA10DEF636DB64978 | catalog.json/records/129/version_updated | Historical; current review incomplete |
H51-F973D028871BF35D8F68C0CC | dailymed-label-snapshots-v5.1.json/records/32/id | Historical; current review incomplete |
H51-8FDB0C4CF9806608243DF9F2 | dailymed-label-snapshots-v5.1.json/records/32/catalog_name | Historical; current review incomplete |
H51-17B8250B15AD185B5E61F776 | dailymed-label-snapshots-v5.1.json/records/32/selection_status | Historical; current review incomplete |
H51-138150F57170EF915D8A59B7 | dailymed-label-snapshots-v5.1.json/records/32/confidence | Historical; current review incomplete |
H51-0E760427BE5A5166462C050F | dailymed-label-snapshots-v5.1.json/records/32/match_path | Historical; current review incomplete |
H51-CA7885C3B3BC150754F8B4FA | dailymed-label-snapshots-v5.1.json/records/32/brand_name | Historical; current review incomplete |
H51-0AC06EC6CB52C714DFE0A273 | dailymed-label-snapshots-v5.1.json/records/32/label_title | Historical; current review incomplete |
H51-4EAFCFE617D6084950BAB09D | dailymed-label-snapshots-v5.1.json/records/32/setid | Historical; current review incomplete |
H51-3D29FBE53570FD2D11F52673 | dailymed-label-snapshots-v5.1.json/records/32/route | Historical; current review incomplete |
H51-D2544D5E6E64C8E610DB7A98 | dailymed-label-snapshots-v5.1.json/records/32/dosage_form | Historical; current review incomplete |
H51-7076B5E10128C27967C8FA0A | dailymed-label-snapshots-v5.1.json/records/32/dosage_administration_summary/0 | Historical; current review incomplete |
H51-D1D880E3DF4042A3AEC63895 | dailymed-label-snapshots-v5.1.json/records/32/dosage_administration_summary/1 | Historical; current review incomplete |
H51-7CDA2FB6EE52ED1A55638965 | dailymed-label-snapshots-v5.1.json/records/32/dosage_administration_summary/2 | Historical; current review incomplete |
H51-646E7788CE07A22131B85509 | dailymed-label-snapshots-v5.1.json/records/32/dosage_forms_strengths/0 | Historical; current review incomplete |
H51-B51AAE41E4060D053EBEA5A8 | dailymed-label-snapshots-v5.1.json/records/32/mechanism_summary | Historical; current review incomplete |
H51-12497F4ACCB27F4307DD02B0 | dailymed-label-snapshots-v5.1.json/records/32/scope_note | Historical; current review incomplete |
H51-2D2599628128111DE3D9999C | dailymed-label-snapshots-v5.1.json/records/32/labeler | Historical; current review incomplete |
H51-187B35DAEEE0FE267AC5C2E4 | dailymed-label-snapshots-v5.1.json/records/32/official_label_url | Historical; current review incomplete |
H51-5D15113877AC41937F990CA9 | dailymed-label-snapshots-v5.1.json/records/32/reviewed_on | Historical; current review incomplete |
H51-01A45FA2B5879F2E4970841B | dailymed-label-snapshots-v5.1.json/records/32/mechanism_source | Historical; current review incomplete |
H51-231516268E239129456D482E | dailymed-label-snapshots-v5.1.json/records/32/source_sections/0 | Historical; current review incomplete |
H51-8053F1723EBC73E8C848F80D | dailymed-label-snapshots-v5.1.json/records/32/source_sections/1 | Historical; current review incomplete |
H51-BC08ACF7335468C2E313DDB5 | dailymed-label-snapshots-v5.1.json/records/32/source_sections/2 | Historical; current review incomplete |
H51-925FD0AF51F935F0D4CDB469 | dailymed-label-snapshots-v5.1.json/records/32/retrieval_method | Historical; current review incomplete |
H51-211AEA885BA35A30C8428643 | dailymed-label-snapshots-v5.1.json/records/32/label_status | Historical; current review incomplete |
H51-448BD7C133CD2CB050445D09 | dailymed-label-snapshots-v5.1.json/records/32/disclaimer | Historical; current review incomplete |
H51-193BDC23BF4ACE663F597E8C | dosing.json/records/129/id | Historical; current review incomplete |
H51-554FCFE0C6853E4FD7477F81 | dosing.json/records/129/generic_name | Historical; current review incomplete |
H51-997AAFA4D7078E388DE64DFF | dosing.json/records/129/coverage_status | Historical; current review incomplete |
H51-28619DD1D3C04E3864F6AD4D | dosing.json/records/129/package_insert/query_name | Historical; current review incomplete |
H51-526EDF2720B66FFF3707BBF4 | dosing.json/records/129/package_insert/preferred_setid | Historical; current review incomplete |
H51-4AB3D4BE5A126D782558C02C | dosing.json/records/129/package_insert/product_and_route_must_match | Historical; current review incomplete |
H51-6D12CFD848ABA5AA323E4D9C | dosing.json/records/129/package_insert/live_current_label_enabled | Historical; current review incomplete |
H51-F641B02449CFEC22D54F034F | dosing.json/records/129/package_insert/source_priority | Historical; current review incomplete |
H51-834E7E6E9304379A6B0B6702 | dosing.json/records/129/package_insert/direct_official_label_access_enabled | Historical; current review incomplete |
H51-D5ADAA0F84ECB7150BC10DEE | dosing.json/records/129/package_insert/outbound_server_request_required | Historical; current review incomplete |
H51-05EFC59544D0690908B5C799 | dosing.json/records/129/package_insert/local_summary_status | Historical; current review incomplete |
H51-B710C79FEF398C3CC49FC8B9 | dosing.json/records/129/renal/classification | Historical; current review incomplete |
H51-C45451674211177D9035D2D4 | dosing.json/records/129/renal/summary | Historical; current review incomplete |
H51-FF6515CA37F0BCE43D7C0119 | dosing.json/records/129/renal/method_note | Historical; current review incomplete |
H51-842F7E111DD4A5759412BAB7 | dosing.json/records/129/existing_route_snapshots/0 | Historical; current review incomplete |
H51-525AAB716F36C184C04D1B98 | dosing.json/records/129/existing_route_snapshots/0/route | Historical; current review incomplete |
H51-448767A1266E0F1E16C94FDE | dosing.json/records/129/existing_route_snapshots/0/population | Historical; current review incomplete |
H51-7D1275A01FF9C110A25325BE | dosing.json/records/129/existing_route_snapshots/0/indication | Historical; current review incomplete |
H51-D8081A985FB9F0D336DC107A | dosing.json/records/129/existing_route_snapshots/0/dose | Historical; current review incomplete |
H51-81081F7F9C838E094541413C | dosing.json/records/129/existing_route_snapshots/0/interval | Historical; current review incomplete |
H51-18225BDC3E0649ECA8D392B2 | dosing.json/records/129/existing_route_snapshots/0/duration | Historical; current review incomplete |
H51-1ABC4A4DD96982FDDC61955F | dosing.json/records/129/existing_route_snapshots/0/administration | Historical; current review incomplete |
H51-BC801E317DA0CA5C7AA94317 | dosing.json/records/129/existing_route_snapshots/0/source_level | Historical; current review incomplete |
H51-8859EC958419D3092E0F76E6 | dosing.json/records/129/existing_route_snapshots/0/notes | Historical; current review incomplete |
H51-3FB9CB59460B7C159044362C | dosing.json/records/129/existing_route_snapshots/1 | Historical; current review incomplete |
H51-883E3EDA822D310834E04A63 | dosing.json/records/129/existing_route_snapshots/1/route | Historical; current review incomplete |
H51-DFD39E9CF5D6AE63461272D0 | dosing.json/records/129/existing_route_snapshots/1/population | Historical; current review incomplete |
H51-03F659456B4EE72B718CDCEB | dosing.json/records/129/existing_route_snapshots/1/indication | Historical; current review incomplete |
H51-07D74C4C4F3DA5B06CC8EA2E | dosing.json/records/129/existing_route_snapshots/1/dose | Historical; current review incomplete |
H51-382F542F29FCB4F50699E4E4 | dosing.json/records/129/existing_route_snapshots/1/interval | Historical; current review incomplete |
H51-A6B813666A0CFFF1ADC87E83 | dosing.json/records/129/existing_route_snapshots/1/duration | Historical; current review incomplete |
H51-3F4099A4B364BC163712011D | dosing.json/records/129/existing_route_snapshots/1/administration | Historical; current review incomplete |
H51-C38EAF957107983D4D8052D0 | dosing.json/records/129/existing_route_snapshots/1/source_level | Historical; current review incomplete |
H51-E602BC10F95F428B19BE3338 | dosing.json/records/129/existing_route_snapshots/1/notes | Historical; current review incomplete |
H51-8C20C0CFDDF694416DA0953D | dosing.json/records/129/clinical_review/locally_normalized | Historical; current review incomplete |
H51-FD74E839CFF62652A506A1B1 | dosing.json/records/129/clinical_review/reviewed | Historical; current review incomplete |
H51-AFADD37DD574DFD8C9B76727 | dosing.json/records/129/clinical_review/status | Historical; current review incomplete |
H51-27DF97C4C04325FBCEF149D7 | dosing.json/records/129/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-17A9178607E66636729D6BD5 | dosing.json/records/129/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-265EFA157CD77E3D5589A0DE | dosing.json/records/129/clinical_release_verification/level | Historical; current review incomplete |
H51-9A424B3E5711BC7961DCE30F | dosing.json/records/129/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-C9772B460FCC84F7103CB10A | dosing.json/records/129/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-2493CC593FCA322F61360147 | dosing.json/records/129/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-D12E345B1CFBE500507816CF | dosing.json/records/129/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-2C860C70D93B76FD227F323F | dosing.json/records/129/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-F0C98988EF97064BE09CDEF6 | dosing.json/records/129/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-6933720BAD9BC04F117D926C | dosing.json/records/129/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-DE110D4A4980EAF4BBDA0BCE | dosing.json/records/129/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-9A4EEB30DE3A902126980569 | dosing.json/records/129/clinical_release_verification/note | Historical; current review incomplete |
H51-318C2FC9E2807ECF9D72E254 | dosing.json/records/129/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-D425D3C5C1D93A87BEB6589F | first-look-v5.1.json/records/129/id | Historical; current review incomplete |
H51-13B65B862AAD2A77FDF1A809 | first-look-v5.1.json/records/129/generic_name | Historical; current review incomplete |
H51-B691EB5E7652A59250A19658 | first-look-v5.1.json/records/129/class | Historical; current review incomplete |
H51-2297D326132C2D9B96987322 | first-look-v5.1.json/records/129/subclass | Historical; current review incomplete |
H51-72C07DAD363E0C354E92DE2D | first-look-v5.1.json/records/129/primary_uses/0 | Historical; current review incomplete |
H51-E33D492F0E9C33600B6F8958 | first-look-v5.1.json/records/129/mechanism | Historical; current review incomplete |
H51-38995DC515320B76BEAFD262 | first-look-v5.1.json/records/129/mechanism_level | Historical; current review incomplete |
H51-E59DAD5CA1E2ACC26C125F46 | first-look-v5.1.json/records/129/basic_dosing_orientation | Historical; current review incomplete |
H51-FBB8C9B5844EFB523616D982 | first-look-v5.1.json/records/129/administration_orientation | Historical; current review incomplete |
H51-B361FDE6863C4BD1CBF069C1 | first-look-v5.1.json/records/129/renal_and_population_orientation | Historical; current review incomplete |
H51-42CFBA0D49E49B5A34D686F9 | first-look-v5.1.json/records/129/key_safety_orientation/0 | Historical; current review incomplete |
H51-05C76B362C48ECA8A3D1FCED | first-look-v5.1.json/records/129/key_safety_orientation/1 | Historical; current review incomplete |
H51-FA4E0E7130FC0382E756184E | first-look-v5.1.json/records/129/coverage_path | Historical; current review incomplete |
H51-CA049176351522CB42DFB9D9 | first-look-v5.1.json/records/129/coverage_path_label | Historical; current review incomplete |
H51-6F3EC70A40011E5B57BD46FD | first-look-v5.1.json/records/129/official_label_url | Historical; current review incomplete |
H51-FE83BE84324857E7AD6025A2 | first-look-v5.1.json/records/129/legacy_title | Historical; current review incomplete |
H51-63411640276E16771108B302 | first-look-v5.1.json/records/129/review_note | Historical; current review incomplete |
H51-2EE4B1F98535ED837F0743C5 | first-look-v5.1.json/records/129/search_text | Historical; current review incomplete |
H51-2E171AB02C817B9CB776E72F | first-look-v5.1.json/records/129/official_search_url | Historical; current review incomplete |
H51-A32838FE1D5C9B21A487763B | first-look-v5.1.json/records/129/official_access_mode | Historical; current review incomplete |
H51-D251AED467AF911FCBD41695 | first-look-v5.1.json/records/129/official_access_url | Historical; current review incomplete |
H51-93F59502D4BC6B167D77C358 | first-look-v5.1.json/records/129/official_search_query | Historical; current review incomplete |
H51-E570F75735AE2027BED6F35E | first-look-v5.1.json/records/129/official_access_reason | Historical; current review incomplete |
H51-89C5DFCADA3FD061B32C543B | first-look-v5.1.json/records/129/label_snapshot_available | Historical; current review incomplete |
H51-6E7D9C2E47C17242DBFEEC1C | first-look-v5.1.json/records/129/label_snapshot_setid | Historical; current review incomplete |
H51-969D994CD233FA475C6F41C6 | preparation-assessments-v3.8.json/129/id | Historical; current review incomplete |
H51-A6F593EAACA74C002EA65D71 | preparation-assessments-v3.8.json/129/name | Historical; current review incomplete |
H51-ADB11FA580DEBD2F900C9DE6 | preparation-assessments-v3.8.json/129/brands | Historical; current review incomplete |
H51-3FEC019B9213A06AB03479F3 | preparation-assessments-v3.8.json/129/therapeutic_class | Historical; current review incomplete |
H51-06B5D780BAF41AD98EFA918D | preparation-assessments-v3.8.json/129/review_version | Historical; current review incomplete |
H51-B77A9D9C481333EAC6D9E51F | preparation-assessments-v3.8.json/129/review_date | Historical; current review incomplete |
H51-E5E834CD3BB12AF7B41FF7E9 | preparation-assessments-v3.8.json/129/release_status | Historical; current review incomplete |
H51-6886354A7424D580A2A76EA7 | preparation-assessments-v3.8.json/129/market_status/status | Historical; current review incomplete |
H51-E5E57CE1DC5E227E458F1D69 | preparation-assessments-v3.8.json/129/market_status/basis | Historical; current review incomplete |
H51-5C3F03959F27D49C39FF769F | preparation-assessments-v3.8.json/129/ten_point_assessment/exact_formulation | Historical; current review incomplete |
H51-7FA43A82321ACC02A0C8DADE | preparation-assessments-v3.8.json/129/ten_point_assessment/reconstitution_concentration | Historical; current review incomplete |
H51-63255401EAEB350271695E21 | preparation-assessments-v3.8.json/129/ten_point_assessment/maximum_or_recommended_final_concentration | Historical; current review incomplete |
H51-C4D6E45E19C6C1BFD831DD86 | preparation-assessments-v3.8.json/129/ten_point_assessment/appropriate_standardized_containers | Historical; current review incomplete |
H51-52D8383631E04584E45F5A8F | preparation-assessments-v3.8.json/129/ten_point_assessment/adult_dosing_range | Historical; current review incomplete |
H51-34FE23093F74BE63D92732CE | preparation-assessments-v3.8.json/129/ten_point_assessment/pediatric_dosing_range | Historical; current review incomplete |
H51-78C75C98D369F66A94068244 | preparation-assessments-v3.8.json/129/ten_point_assessment/neonatal_dosing_range | Historical; current review incomplete |
H51-C2CD417F336254695D9C6869 | preparation-assessments-v3.8.json/129/ten_point_assessment/infusion_time | Historical; current review incomplete |
H51-9169A4B5B767D7F2933BE5E0 | preparation-assessments-v3.8.json/129/ten_point_assessment/fluid_restriction_alternatives | Historical; current review incomplete |
H51-AC98E42F31DD3C6DA27ADA1E | preparation-assessments-v3.8.json/129/ten_point_assessment/current_manufacturer_labeling/setid | Historical; current review incomplete |
H51-656EEFF6C4BE00D89ADAA6D2 | preparation-assessments-v3.8.json/129/ten_point_assessment/current_manufacturer_labeling/title | Historical; current review incomplete |
H51-5FC9AE3D736F277B154C9461 | preparation-assessments-v3.8.json/129/ten_point_assessment/current_manufacturer_labeling/published_date | Historical; current review incomplete |
H51-77A7A8AEAE1C6EE0B31D6A47 | preparation-assessments-v3.8.json/129/ten_point_assessment/current_manufacturer_labeling/manufacturer | Historical; current review incomplete |
H51-3172F777C16A3387C3188E3F | preparation-assessments-v3.8.json/129/ten_point_assessment/current_manufacturer_labeling/match_confidence | Historical; current review incomplete |
H51-F582DD939ADE9686D98EB631 | preparation-assessments-v3.8.json/129/ten_point_assessment/current_manufacturer_labeling/url | Historical; current review incomplete |
H51-1761C6E852151C6D9EF949E6 | preparation-assessments-v3.8.json/129/field_provenance/exact_formulation/primary | Historical; current review incomplete |
H51-35039B70F884519E01154615 | preparation-assessments-v3.8.json/129/field_provenance/reconstitution_concentration/primary | Historical; current review incomplete |
H51-FB9C0190F6548E04BC51241C | preparation-assessments-v3.8.json/129/field_provenance/maximum_or_recommended_final_concentration/primary | Historical; current review incomplete |
H51-78F22C7DFF9C6E57FE76C76E | preparation-assessments-v3.8.json/129/field_provenance/appropriate_standardized_containers/primary | Historical; current review incomplete |
H51-C8CE013F55EFC8A4A7154CC2 | preparation-assessments-v3.8.json/129/field_provenance/adult_dosing_range/primary | Historical; current review incomplete |
H51-B020B4A4C4A7C329E5E71A2F | preparation-assessments-v3.8.json/129/field_provenance/pediatric_dosing_range/primary | Historical; current review incomplete |
H51-2DE0FC1EE1FCB543BFAF065A | preparation-assessments-v3.8.json/129/field_provenance/neonatal_dosing_range/primary | Historical; current review incomplete |
H51-2B8CC2BAEEF84BF0E2534FA2 | preparation-assessments-v3.8.json/129/field_provenance/infusion_time/primary | Historical; current review incomplete |
H51-24231D9DD865B437089E8028 | preparation-assessments-v3.8.json/129/field_provenance/fluid_restriction_alternatives/primary | Historical; current review incomplete |
H51-31BF1A82566EA794B8FFBD21 | preparation-assessments-v3.8.json/129/field_provenance/current_manufacturer_labeling/primary | Historical; current review incomplete |
H51-99B73EB39DBE80BF2D794024 | preparation-assessments-v3.8.json/129/population_applicability/adult/applicability | Historical; current review incomplete |
H51-D00DF60D6F7448B528B63579 | preparation-assessments-v3.8.json/129/population_applicability/adult/guide_generation_allowed | Historical; current review incomplete |
H51-1246B35092D9EC45D3F56F93 | preparation-assessments-v3.8.json/129/population_applicability/pediatric/applicability | Historical; current review incomplete |
H51-19DA0488129D1241E4C81204 | preparation-assessments-v3.8.json/129/population_applicability/pediatric/guide_generation_allowed | Historical; current review incomplete |
H51-A1BCBB598FDB2FCFE4D1B0B5 | preparation-assessments-v3.8.json/129/population_applicability/neonatal/applicability | Historical; current review incomplete |
H51-9C17AF0A2A2ADD03014B50A4 | preparation-assessments-v3.8.json/129/population_applicability/neonatal/guide_generation_allowed | Historical; current review incomplete |
H51-8CDB06D0F114C10D388A8E0A | preparation-assessments-v3.8.json/129/route_presence/structured_dilution | Historical; current review incomplete |
H51-FDAD7539776AE1CC1EF99EED | preparation-assessments-v3.8.json/129/route_presence/iv_push | Historical; current review incomplete |
H51-29051919617A43CBC4D4D64D | preparation-assessments-v3.8.json/129/route_presence/continuous_infusion | Historical; current review incomplete |
H51-A5ABF1E41C38472B2F461670 | preparation-assessments-v3.8.json/129/route_presence/pediatric_source | Historical; current review incomplete |
H51-42E098ECD5E3DE2936E04B41 | preparation-assessments-v3.8.json/129/route_presence/neonatal_source | Historical; current review incomplete |
H51-F9FE69A92F5779B604B06F0F | preparation-assessments-v3.8.json/129/legacy_reference/status | Historical; current review incomplete |
H51-009719E5ED069627D6B96DD0 | preparation-assessments-v3.8.json/129/label_resolution/status | Historical; current review incomplete |
H51-E62740C39C45595C431ADF56 | preparation-assessments-v3.8.json/129/source_files/0 | Historical; current review incomplete |
H51-B00743281AD1905E034CA195 | preparation-assessments-v3.8.json/129/source_files/1 | Historical; current review incomplete |
H51-06B26B15ADDFC93DDEC75921 | preparation-assessments-v3.8.json/129/source_files/2 | Historical; current review incomplete |
H51-0628910E5DE890F166C90C81 | preparation-assessments-v3.8.json/129/clinical_release_note | Historical; current review incomplete |